Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model

Molecular Human Reproduction

Volumn 15, Issue 10, 2009, Pages 633-643

  Mönckedieck, Verena ^a   Sannecke, Carolin ^a   Husen, Bettina ^b   Kumbartski, Michael ^a   Kimmig, Rainer ^a   Tötsch, Martin ^a   Winterhager, Elke ^a   Grümmer, Ruth ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Angiogenesis; Dydrogesterone; Endometriosis; MMP; Progestins

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; DIHYDRODYDROGESTERONE; DYDROGESTERONE; ESTROGEN RECEPTOR ALPHA; GELATINASE A; GELATINASE B; GESTAGEN; MATRILYSIN; MATRIX METALLOPROTEINASE; PROGESTERONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; STROMELYSIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; DRUG MECHANISM; DRUG SCREENING; ECTOPIC TISSUE; ENDOMETRIOSIS; EXTRACELLULAR MATRIX; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CYSTEINE-RICH PROTEIN 61; DYDROGESTERONE; ENDOMETRIUM; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; PROGESTERONE; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS MUSCULUS;

EID: 70349413083     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gap063     Document Type: Article

References (44)

1. Absenger Y, Hess-Stumpp H, Kreft B, Krätzschmar J, Haendler B, Schütze N, Regidor PA, Winterhager E. CYR61, a deregulated gene in endometriosis. Mol Hum Reprod 2004;10:399-407.
2. Brigstock D. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine rich 61 (CYR61). Angiogenesis 2002;5:153-165.
3. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002;87 4782-4791.
4. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007; 148:3814-3826.
5. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-159.
6. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci 2002;55:11-22.
7. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
8. Fechner S, Husen B, Thole H, Schmidt M, Gashaw I, Kimmig R, Winterhager E, Grümmer R. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 2007; 88(Suppl 4):1029-1038.
9. Ferriana RA, Charnock-Jones DS, Prentice A, Thomas EJ, Smith SK. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 1993;8 11-16.
10. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A. Expression of angiogenic factors in endometriosis: Relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007;22:2120-2127.
11. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
12. Groothuis PG, Nap AW, Winterhager E, Grümmer R. Vascular development in endometriosis. Angiogenesis 2005;8:147-156.
13. Grümmer R. Animal models in endometriosis research. Hum Reprod Update 2006;12:641-649.
14. Grümmer R, Schwarzer F, Bainczyk K, Hess-Stumpp H, Regidor PA, Schindler AE, Winterhager E. Peritoneal endometriosis: Validation of an in-vivo model. Hum Reprod 2001;16:1736-1743.
15. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003; 88:2889-2899.
16. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavaré S, Print CG, Charnock-Jones DS. Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 2008;173:700-715.
17. Hyder S, Stancel G. Regulation of angiogenic growth factors in the female, reproductive tract by estrogens and progestins. Mol Endocrinol 1999; 13:806-811.
18. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril 2006; 85 564-572.
19. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007;13:331-342.
20. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 1992;89 11789-11793.
21. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy PJ, Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 1995;305:1027-1030.
22. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
23. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-223.
24. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002;22:8709-8720.
25. Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review). The Cochrane Library. Oxford: Update Software, 2003.
26. Nap AW, Griffioen AW, Dunselman GA, Bouma-Tersteege JCA, Thijssen VLJL, Evers JL, Groothuis PG. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004;89:1089-1095.
27. Nisolle M, Casanas-Roux F, Marbaix E, Jadoul P, Donnez J. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod 2000;15:572-577.
28. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
29. Olive DL, Pritts EA. The treatment of endometriosis: A review of the evidence. Ann N Y Acad Sci 2002;955:360-372.
30. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 1994;91:10129-10133.
31. Osteen KG, Bruner-Tran KL, Ong D, Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinase expression: Potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci 2002; 955:139-146.
32. Overton CE, Lindsay PC, Johal B, Collins SA, Siddle NC, Shaw RW, Barlow DH. A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril 1994;62:701-707.
33. Ria R, Loverro G, Vacca A, Ribatti D, Cormio G, Roccaro AM, Selvaggi L. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest 2002;32:199-206.
34. Saito T, Mizumoto H, Kuroki K, Fujii M, Mori S, Kudo R. Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol. Acta Obstet Gynecol Jpn 1995;47:495-496.
35. Sampson JA. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940;40: 549-557.
36. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 2006;85:314-325.
37. Seli E, Zeyneloglu HB, Senturk LM, Bahtiyar OM, Olive DL, Arici A. Basic fibroblast growth factor: Peritoneal and follicular fluid level and its effect on early embryonic development. Fertil Steril 1998;69 1145-1148.
38. Shifren J, Tseng J, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-3118.
39. Somigliana E, Vigano P, Barbara G, Vercellini P. Treatment of endometriosis-related pain: Options and outcomes. Front Biosci 2009;1:455-465.
40. Spuijbroek MDEH, Dunselman GJ, Menmeere PPCA, Evers JLH. Early endometriosis invades the extracellular matrix. Fertil Steril 1992; 58:929-933.
41. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004;35:1369-1375.
42. Trivedi P, Selvaraj K, Mahapatra PD, Srivastava S, Malik S. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecol Endocrinol 2007;23(Suppl 1):73-76.
43. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: Forward to the past. Hum Reprod Update 2003;9:387-396.
44. Wenzl RJ, Heinzl H. Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 1998; 45:253-257.